Showing results (601-610 of 901) with videos related to
Sort By:
Pageof 91
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803Jeffrey A Meyerhardt, Denise Heseltine, Donna Niedzwiecki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumorsGary K Schwartz, Eileen O'Reilly, David Ilson, et al.Nutrition and Cancer|February 4, 2015
Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysisKathleen M Wesa, Neil H Segal, Angel M Cronin, et al.Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentationJoseph Herman, Wells Messersmith, W Warren Suh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatmentGeorge A Poultsides, Elliot L Servais, Leonard B Saltz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.The Journal of Clinical Investigation|January 20, 2016
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesisAlexander Nguyen, Jia Min Loo, Rohit Mital, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeksS Sharma, N Kemeny, G K Schwartz, et al.Annals of Surgery|July 20, 2002
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapyLeyo Ruo, Satish Tickoo, David S Klimstra, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2005
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization studyJinru Shia, David S Klimstra, Allan R Li, et al.Pageof 91